Email updates

Keep up to date with the latest news and content from BMC Pharmacology and Toxicology and BioMed Central.

Open Access Research article

Impact of information letters on the reporting rate of adverse drug reactions and the quality of the reports: a randomized controlled study

Marie-Louise Johansson1, Staffan Hägg2 and Susanna M Wallerstedt1*

Author Affiliations

1 Department of Clinical Pharmacology and Regional Pharmacovigilance Centre, Sahlgrenska University Hospital, Gothenburg, Sweden

2 Department of Drug Research/Clinical Pharmacology, Linköping University, Linköping, Sweden

For all author emails, please log on.

BMC Clinical Pharmacology 2011, 11:14  doi:10.1186/1472-6904-11-14

Published: 7 September 2011

Additional files

Additional file 1:

ADR information letter I. The first ADR information letter sent to physicians and nurses in the intervention units (translated to English).

Format: DOC Size: 33KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 2:

ADR information letter II. The second ADR information letter sent to physicians and nurses in the intervention units (translated to English).

Format: DOC Size: 26KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 3:

ADR information letter III. The third ADR information letter sent to physicians and nurses in the intervention units (translated to English).

Format: DOC Size: 26KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data

Additional file 4:

Questionnaire. Questionnaire sent to physicians and nurses in intervention and control units (translated to English).

Format: DOC Size: 45KB Download file

This file can be viewed with: Microsoft Word Viewer

Open Data